Sartorius Stedim Biotech Investor Relations

Nine-Month 2015 Results

Investor Relations News: January to September 2015 (258 KB)

Facts & Figures

Download a brief overview of Sartorius Stedim Biotech and its current economic development.

Fact Sheet Sartorius Stedim Biotech, 9M|2015 (209 KB)

Reference Document 2014

Download pdf  (2.6 MB)
Download Excel files (124 KB)


New ambr® 15 fermentation Micro Scale Bioreactor System Provides Enhanced Microbial Strain Screening with Fed-Batch Capability

Goettingen, GER | Cambridge, UK – November 3, 2015: Sartorius Stedim Biotech (SSB), an international leading supplier for the biopharmaceutical industry, today introduced the new ambr® 15...[more]

Date 03.11.2015     Category Products, Sartorius Stedim Biotech

Sartorius Stedim Biotech continues strong growth

€ in millionsunless otherwise specifiedUnaudited figures9 months 20159 months 2014Growth in %Growth in %const. fx Order intake694.0509.736.224.9Sales...[more]

Date 20.10.2015     Category Corporate, Sartorius Stedim Biotech